bionik labs
  • Solutions
    • InMotion Interactive Therapy
    • InMotion ARM™
    • InMotion ARM/HAND™
    • InMotion Connect™
    • Technology Upgrade
  • Evidence
    • Published Research
    • Clinical Guidelines
    • Testimonials
  • News
    • Media Coverage
    • Press Releases
  • Events
    • Webinar Series
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • RESOURCES
    • Cleaning Procedures
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

Bionik Laboratories Issues Letter to Stockholders

Apr 3, 2018

Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors

Mar 20, 2018

Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea

Mar 7, 2018

Bionik Laboratories Reports Third Quarter Fiscal Year 2018 Financial Results

Feb 13, 2018

Bionik Laboratories Corp. Launches New Commercial Generation InMotion Arm Robotic System to Improve Rehabilitation for Stroke Survivors

Feb 5, 2018

Bionik Laboratories Corp. Appoints Andre Auberton-Herve as Chairman of Board of Directors

Jan 29, 2018

Bionik Laboratories Reports Second Quarter Fiscal Year 2018 Financial Results

Nov 14, 2017

Bionik Laboratories Corp. Announces Capital Raise through Issuance of Convertible Notes

Sep 21, 2017

Bionik Laboratories Postpones 2017 Annual Meeting of Stockholders

Sep 12, 2017

Bionik Laboratories Corp. Appoints Dr. Eric Dusseux as Chief Executive Officer

Sep 7, 2017
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • Solutions
    • About Us
    • Investors
    • Disclaimer
    • Privacy Policy
    • NEWS + EVENTS
    • Recent News
    • Upcoming Events
    • Press Releases
    • SUPPORT
    • Contact Us
    bionik

    Global Headquarters

    483 Bay Street
    Office N105
    Toronto, ON M5G 2C9
    Canada

    Tel: 1.416.649.7887
    info@bioniklabs.com

    U.S. Headquarters

    80 Coolidge Hill Road,
    Watertown, MA 02472
    United States

    Tel: 1.617.926.4800
    support@bioniklabs.com

    © 2021 BIONIK
    Facebook Twitter LinkedIn